The Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Amendment (No. 2) Order 1995

Type Statutory-Instrument
Publication 1995-12-06
State In force
Department Queen's Printer of Acts of Parliament
PDF Download
articles Not indexed
Reform history JSON API

Made: 6th December 1995

Laid before Parliament: 8th December 1995

Coming into force: 29th December 1995

The Secretaries of State concerned with health in England, in Wales and in Scotland respectively and the Department of Health and Social Services for Northern Ireland, acting jointly, in exercise of powers conferred on them by sections 58(1), (4) and (5) and 129(4) of the Medicines Act 1968[^f00001] or, as the case may be, those conferred by the said provisions and now vested in them[^f00002], and of all other powers enabling them in that behalf, after consulting such organisations as appear to them to be representative of interests likely to be substantially affected by this Order, pursuant to section 129(6) of that Act, and after consulting and taking into account the advice of the Medicines Commission pursuant to sections 58(6) and 129(7) of that Act, hereby make the following Order:

Citation, commencement and interpretation

1

Amendment of article 1 of the principal Order

2

In article 1(2) of the principal Order (interpretation), for the definition of “maximum strength” there is substituted the following definition—

  • “maximum strength” means such of the following as may be specified— the maximum quantity of a substance by weight or volume contained in a dosage unit of a medicinal product; the maximum number of units of activity contained in a dosage unit or a weight of a medicinal product; and the maximum percentage of a substance contained in a medicinal product calculated in terms of weight in weight, weight in volume, volume in weight or volume in volume, as appropriate;

Amendment of article 3 of the principal Order

3

In article 3(1)(a) of the principal Order (medicinal products on prescription only), for “Article 4(1) to (1Z)” there is substituted “Article 4(1) to (1AA)”.

Amendment of article 4 of the principal Order

4

In article 4 of the principal Order (medicinal products that are not prescription only)—

(1AA) Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance budesonide where— (a) the medicinal product is indicated only for the prevention or treatment of seasonal allergic rhinitis in adults and in children aged not less than 12 years; (b) it is in non-aerosol, aqueous form for nasal administration; (c) it is sold or supplied in a container or package containing not more than 10 milligrams of the medicinal product; and (d) the container or package is labelled to show a maximum dose, and a maximum daily dose, of 200 micrograms per nostril of budesonide.

Amendment of Part I of Schedule 1 to the principal Order

5

In Part I of Schedule 1 to the principal Order (which lists substances which render a medicinal product a prescription only medicine except in the circumstances also Listed)

(1) 21,000 European Pharmacopoeia units of lipase per capsule (2) 25,000 European Pharmacopoeia units of lipase per gram

(1) capsules (2) powder

Signed

Signed by authority of the Secretary of State for Health

John Horam — Parliamentary under Secretary of State, — Department of Health — 1st December 1995

William Hague — Secretary of State for Wales — 6th December 1995

James Douglas Hamilton — Minister of State, The Scottish Office — 6th December 1995

Sealed with the Official Seal of the Department of Health and Social Services for Northern Ireland on

F. A. Elliot — Permanent Secretary — 5th December 1995.

Explanatory note

(This note is not part of the Order)

This Order further amends the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Order 1983 (“the principal Order”) which specifies descriptions and classes of prescription only medicines (i.e. medicinal products which, subject to exemptions, may be sold or supplied by retail only in accordance with a prescription given by an appropriate practitioner and which may be administered only by or in accordance with the directions of such a practitioner). Under the principal Order products are included in a class of such medicines by reason of the substances contained in them, subject to their being excluded in certain specified circumstances.

The amendments made by this Order are as follows:—

Footnotes

[^f00001]: 1968 c. 67. The expressions “the appropriate Ministers” and “the Health Ministers” are defined in section 1 of that Act as amended by S.I. 1969/388, Schedule 1.

[^f00002]: In the case of the Secretaries of State concerned with health in England and in Wales by virtue of article 2(2) of, and Schedule 1 to, the Transfer of Functions (Wales) Order 1969 (S.I. 1969/388); in the case of the Department of Health and Social Services for Northern Ireland by virtue of section 40 of, and Schedule 5 to, the Northern Ireland Constitution Act 1973 (c. 36) and section 1(3) of, and paragraph 2(1)(b) of Schedule 1 to, the Northern Ireland Act 1974 (c. 28).

[^f00003]: S.I. 1983/1212, amended by S.I. 1984/756, 1986/586, 1987/674 and 1250, 1988/2017, 1989/1852, 1991/962, 1992/1534 and 2937, 1993/1890 and 3256, 1994/558, 3016 and 3050 and 1995/1384.

Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.

This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence. legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.